Charting New Paths: Non-TNF’s Evolving in Rheumatoid Arthritis Market
EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) — Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar counterparts,